Single-cell transcriptomics (scRNA-seq) and open chromatin accessibility (scATAC-seq) have been the two most widely used -omics modalities thus far, enabling unprecedented dissection of tumor composition and functional state, in both IDH-wild-type and IDH-mutant diffuse gliomas. This evidence concerns the gene IDH2 and neoplasm.